Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBT-1 plus Paclitaxel/Carboplatin in Inoperable NSCLC
NCT00437749Phase 3Terminated
- Sponsor
- CBA Pharma, Inc.
- Start
- Aug 2001
- Primary completion
- Jul 2010
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tetrandrine in non-small cell lung cancer (NSCLC), sponsored by CBA Pharma, Inc.. Started Aug 2001; status: terminated.
02
Drugs
tetrandrine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00437749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00437749.